- Global Pharma News & Resources

Global erectile dysfunction drugs market is set to grow annually at a rate of around 5.0%

Erectile dysfunction or disorder (ED) is the inability to develop and maintain an erection for satisfactory sexual intercourse or activity. Erectile dysfunction or erectile disorders are the preferred terms as opposed to impotence. There are no uniform criteria defining how consistent the problem has to be and for what duration it must be present to considered ED. The emergence of several unique formulations of erectile dysfunction drugs such as topical gels, injectables, and suppositories is expected to widen the scope of treatment for erectile dysfunction.

According to the research report from Facts and Factors, the global Erectile Dysfunction Drugs market in 2019 is approximately USD 1,923.3 Million. The market is anticipated to grow at a CAGR of 5.0% and is projected to reach around USD 2,687.6 Million by 2026.

The global Erectile Dysfunction Drugs market is driving due to increased vascular disorders followed by the aging population across the world. Furthermore, rising psychological problems, followed by chronic diseases like diabetes, alcohol, and smoking habits are also considered as one of the major driving factors for the growth of the market. The high cost of treatment followed by government stringent regulation is considered as a major restraining factor that curbs the growth of the market. Increasing awareness in Asia Pacific countries is considered one of the major opportunities for the growth of the market during the forecast period.

Get a Free Sample Copy of Research Report Here:

In Drug type, the market is classified into sixtype’sSildenafil Citrate (Viagra), Vardenafil (Levitra/ Staxyn), Tadalafil (Cialis), Udenafil (Zydena), Lodenafil Carbonate (Helleva), Stendra/ Spedra (Avanafil), Mirodenafil (Mvix), and Others. The Sildenafil Citrate (Viagra) accounts for the largest market shares of the Erectile Dysfunction market in the year 2019. VIAGRA works for men with erectile dysfunction (ED) by increasing blood flow to the penis so it can get and keep an erection hard enough for sex.  Results may vary from Person to Person. It’s been proven to help guys with all degrees of ED. VIAGRA usually starts to work within 30-60 minutes.

Based on Mode of Administration, the market is fragmented into two types: Oral Medications, Topical Medications, Injections, and Others. Oral medication Accounted for the largest market share and will remain the same within the forecasted year. The oral administration route is preferred over the various other administration routes of drug delivery due to the many advantages it exhibits. These advantages include safety, good patient compliance, and ease of ingestion, pain avoidance, and versatility to accommodate various types of drugs.

In terms of region, the market is classified into North America, Europe, Asia Pacific, Latin America and the Middle East, and Africa. In North America, the U.S. dominates the market. The patent expiry of leading drugs and increased adoption of alternative treatments are some of the factors responsible for the declining growth of the erectile dysfunction drugs market in the United States. Whereas, Asia Pacific region hits the highest growth of the market and the same will remain the forecasted year. The growth is due to India and China's Population demand.

For More Information, Download a Free Report PDF Brochure:

Top Market Players

The report covers a detailed competitive outlook including company profiles of the key participants operating in the global Erectile DysfunctionDrugs market. The key players of Apricus Biosciences, Bayer AG, Cristália, Eli Lilly and Company, Inc., Pfizer, Inc., Dong-A-Pharmaceutical Co., Ltd., S.K. Chemicals Co., Ltd., Vivus, Inc., Teva Pharmaceutical Industries Ltd., Meda Pharmaceuticals, Inc. and Others

Editor Details

Related Links

Last Updated: 17-Feb-2021